Status:

TERMINATED

Exercise Capacity of Patients with Dermatomyosis

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Dermatomyositis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Dermatomyositis (DM) patients experience muscle weakness and low aerobic capacities, which are associated with poor health status and increased mortality. The origin of this muscle impairment remains ...

Eligibility Criteria

Inclusion

  • Woman or man\> 18 years,
  • Signature of informed consent,
  • Muscle biopsy for suspicion of recent inflammatory myopathy (\<6 months) or for exclusion of neuromuscular pathology.
  • Prospectively, following the results of the muscle biopsy, the subjects will divided into three groups meeting the following criteria:
  • "DM" group: DM according to the ENMC criteria;
  • "other inflammatory myopathy" group: polymyositis, autoimmune necrotizing myopathy, non-specific myositis or inclusion myositis according to the ENMC criteria;
  • Group "no neuromuscular pathology": i) myalgia and / or intolerance to exercise and ii) normal neuromuscular examination, iii) no increase in blood creatine kinase level, iv) absence of electromyographic abnormality, v) histological Muscle mass.

Exclusion

  • \- Taking an immunomodulatory treatment within 6 months before inclusion,
  • Paraneoplastic form of the disease,
  • Presence of associated interstitial pneumonitis,
  • Neuromuscular pathology different from inflammatory myopathy,
  • Unbalanced cardiovascular disease,
  • Impossibility of giving the subject informed information (subject in an emergency situation, difficulty in understanding the subject, ...),
  • Subject under safeguard of justice,
  • Subject under tutelage or under curators,
  • Pregnancy (positive pregnancy test)
  • Breastfeeding.

Key Trial Info

Start Date :

November 28 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2024

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT03293615

Start Date

November 28 2019

End Date

September 1 2024

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Meyer

Strasbourg, France, 67000